Showing 421 - 440 results of 5,085 for search '"cardiovascular"', query time: 0.07s Refine Results
  1. 421

    Cardiovascular Disease and Its Implication for Higher Catastrophic Health Expenditures Among Households in Sub-Saharan Africa by Folashayo Ikenna Peter Adeniji, Taiwo Akinyode Obembe

    Published 2023-03-01
    “…**Background:** Cardiovascular diseases (CVDs) impose an enormous and growing economic burden on households in sub-Saharan Africa (SSA). …”
    Get full text
    Article
  2. 422

    Effects of Tocotrienol on Cardiovascular Risk Markers in Patients With Chronic Kidney Disease: A Randomized Controlled Trial by Liana Trugilho, Lívia Alvarenga, Ludmila Cardozo, Bruna Paiva, Jessyca Brito, Isis Barboza, Jonatas Almeida, Juliana dos Anjos, Pramod Khosla, Marcelo Ribeiro-Alves, Denise Mafra

    Published 2025-01-01
    “…Tocotrienols, isomers of vitamin E, may provide an effective nutritional strategy to mitigate common cardiovascular risks such as dyslipidemia, inflammation, and oxidative stress in patients with chronic kidney disease (CKD). …”
    Get full text
    Article
  3. 423
  4. 424
  5. 425
  6. 426
  7. 427
  8. 428
  9. 429

    Body Fat Equations and Electrical Bioimpedance Values in Prediction of Cardiovascular Risk Factors in Eutrophic and Overweight Adolescents by Franciane Rocha Faria, Eliane Rodrigues Faria, Roberta Stofeles Cecon, Djalma Adão Barbosa Júnior, Sylvia do Carmo Castro Franceschini, Maria do Carmo Gouveia Peluzio, Andréia Queiroz Ribeiro, Pedro Israel Cabral Lira, Paulo Roberto Cecon, Silvia Eloiza Priore

    Published 2013-01-01
    “…The aim of this study was to analyze body fat anthropometric equations and electrical bioimpedance analysis (BIA) in the prediction of cardiovascular risk factors in eutrophic and overweight adolescents. 210 adolescents were divided into eutrophic group (G1) and overweight group (G2). …”
    Get full text
    Article
  10. 430
  11. 431
  12. 432
  13. 433
  14. 434

    Proprotein Convertase Subtilisin/Kexin Type 9: From the Discovery to the Development of New Therapies for Cardiovascular Diseases by Nicola Ferri

    Published 2012-01-01
    “…The identification of the HMG-CoA reductase inhibitors, statins, has represented a dramatic innovation of the pharmacological modulation of hypercholesterolemia and associated cardiovascular diseases. However, not all patients receiving statins achieve guideline-recommended low density lipoprotein (LDL) cholesterol goals, particularly those at high risk. …”
    Get full text
    Article
  15. 435
  16. 436
  17. 437

    Explainable AI associates ECG aging effects with increased cardiovascular risk in a longitudinal population study by Philip Hempel, Antônio H. Ribeiro, Marcus Vollmer, Theresa Bender, Marcus Dörr, Dagmar Krefting, Nicolai Spicher

    Published 2025-01-01
    “…Abstract Aging affects the 12-lead electrocardiogram (ECG) and correlates with cardiovascular disease (CVD). AI-ECG models estimate aging effects as a novel biomarker but have only been evaluated on single ECGs—without utilizing longitudinal data. …”
    Get full text
    Article
  18. 438
  19. 439
  20. 440